Loerop James 4

4 · Aclaris Therapeutics, Inc. · Filed Feb 5, 2026

AI-generated summary of this filing

Updated Feb 5, 2026

Aclaris (ACRS) CBO James Loerop Receives RSUs; Shares Withheld for Taxes

What Happened

James Loerop, Chief Business Officer of Aclaris Therapeutics (ACRS), had 20,875 restricted stock units (RSUs convert/derivative) settle on February 3, 2026. To cover tax withholding, 5,937 of those shares were withheld at $3.47 per share, totaling $20,601. Net shares received from this vesting event were 14,938 (20,875 vested − 5,937 withheld).
This was a vesting/settlement of RSUs (routine compensation event), not an open-market purchase or discretionary sale.

Key Details

Transaction date: 2026-02-03; Filing date (Form 4): 2026-02-05 (timely).
Reported entries: conversion/exercise of derivative (code M) for 20,875 shares; tax withholding (code F) of 5,937 shares at $3.47/share for $20,601.
Shares owned after transaction: Not disclosed in this Form 4.
Footnotes: F1 = each RSU equals a right to one share; F2 = issuer withheld shares to satisfy tax withholding; F3 = these RSUs vest in four equal annual installments starting Feb 3, 2025 (this represents one installment).
Filing shows a standard "sell-to-cover" withholding on RSU settlement rather than a market sale.

Context

This is a routine equity compensation vesting event. The key takeaway for investors is that shares were issued through RSU settlement and some were withheld to pay taxes; it is not a signal of a discretionary insider sale or purchase.

Form 4

Period: 2026-02-03

Chief Business Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-03+20,875→ 198,197 total
Tax Payment
Common Stock
[F2]
2026-02-03$3.47/sh−5,937$20,601→ 192,260 total
Exercise/Conversion
Restricted Stock Units
[F1][F3]
2026-02-03−20,875→ 62,625 total
→ Common Stock (20,875 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
[F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
[F3]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Signature

/s/ Matthew Rothman, Attorney-in-Fact|2026-02-05

1 file